Subretinal fluid left over after anti-VEGF treatment may be associated with better best corrected visual acuity, according to a study.
“Our meta-analysis sought to explore the association between subretinal or intraretinal fluid and best corrected visual acuity in neovascular age-related macular degeneration patients undergoing anti-VEGF therapy,” Peter J. Kertes, MD, told Healio/OSN.
Kertes and colleagues searched the literature for studies that reported on visual acuity stratified by the presence of any residual subretinal fluid (SRF), intraretinal fluid (IRF) or any retinal fluid
Uncategorized